Alice Pomponio

Cancer-Fighting Biotech to Move Research Operations to Dallas After ACS ‘Golden Ticket’ Win

by | Mar 24, 2025
Jibe Therapeutics is developing a next-generation cancer treatment that helps the immune system better recognize and attack tumors. As a result of its "Golden Ticket" pitch competition win, Jibe is relocating its research operations to Dallas' Pegasus Park.
MORE
American Cancer Society’s BrightEdge Golden Ticket Pitch Competition to Be Held at Pegasus Park
by | Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE
Lyda Hill Philanthropies Makes $5.25M Gift to American Cancer Society Venture Capital Arm
by | Nov 6, 2023
The gift, the largest to date for BrightEdge, will fund a "first-of-its-kind program" called the ACS BrightEdge Texas Accelerator. The two-year pilot innovation program will invest in cutting-edge companies making headway in the fight to eliminate cancer.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.